
NHS joint ops disrupted amid bone cement supply problems
Around 1,000 operations a week rely on the product as patients are warned delays are inevitable.
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Notable Quotes
"This is a crushing blow for those individuals who have finally made it to the front of the orthopaedic surgery queue after a long time waiting."
— Deborah Alsina , Executive
"The BOA will update surgeons with developments so they can treat their patients as the situation develops."
— Fergal Monsell , Executive
"The BOA is working with NHS Supply Chain, NHS England and the relevant Specialist Orthopaedic Societies to identify possible alternative supplies and evidence-based practice to reduce the impact on patients."
— Fergal Monsell , Executive
"We trust the Department of Health and Social Care will work hard to address the supply issues given the impact on those waiting in pain whose lives are left on hold."
— Deborah Alsina , Executive
"This is a crushing blow for those individuals who have finally made it to the front of the orthopaedic surgery queue after a long time waiting."
— Deborah Alsina MBE , Executive
Key People
Tags
All Coverage
Around 1,000 operations a week rely on the product as patients are warned delays are inevitable.
The NHS Supply Chain Coordination (NHSSC) provides an update on the global shortage of bone cement products from Heraeus Medical, coordinating with suppliers and NHS England to manage the issue.
A shortage in medical cement is likely to lead to delays in some patients getting joint surgery, NHS bosses say, following a halt in production at Heraeus Medical's main site for two months.
Leeds Teaching Hospitals NHS Trust informs patients about a global shortage of bone cement due to a manufacturing issue, affecting stock levels and potentially leading to postponed elective surgeries.
Arthritis UK expresses concern over the NHS bone cement shortage, which is likely to lead to cancellations and delays for many people with arthritis expecting orthopaedic surgery.
Cambridge University Hospitals NHS Foundation Trust addresses the global shortage of bone cement, explaining the impact on joint replacement surgeries and the prioritization of urgent cases.
Northumbria Healthcare NHS Foundation Trust informs patients about a global shortage of bone cement due to a packaging fault at Heraeus Medical, affecting planned joint replacement operations.
Gloucestershire Hospitals NHS Foundation Trust addresses the national supply issue of bone cement, explaining the impact on planned joint replacement surgeries and the prioritization of urgent cases.
University Hospital Southampton reports a global shortage of bone cement due to a packaging fault at a major supplier, with measures in place to ensure patient safety and continuity of urgent care.
A global shortage of bone cement, caused by a packaging fault at Heraeus Medical, is disrupting NHS operations, with an estimated two-week supply left and potential delays in joint surgeries.
Imperial College Healthcare NHS Trust provides an update on the national shortage of bone cement, advising patients to attend scheduled operations unless contacted otherwise and outlining potential impacts on elective surgeries.
Similar Stories
Related coverage based on topic and tags
'What terminal cancer has taught me about life'
A Gloucestershire man with terminal cancer shares the life lessons he wishes he'd learned sooner.
October 10, 2026 at 06:16 AMWhat happens when you don't know your family medical history?
People who have been adopted or in care sometimes struggle to access family medical history which would be crucial to their own health.
October 10, 2026 at 05:45 AMQuestions remain over Ebola patient who travelled across three nations undetected
Fresh details reveal how the 40-year-old businessman flew and crossed regional borders while seriously ill.
October 10, 2026 at 12:00 AMBoots has a new owner: Three ways it could affect you
The stalwart of Britain's High Street has been sold to a Canadian billionaire family. What will that mean for you?
October 9, 2026 at 11:01 PMUS FDA approves Asahi Kasei's drug for persistent herpes infections - Reuters
US FDA approves Asahi Kasei's drug for persistent herpes infections Reuters
October 9, 2026 at 06:01 PMUS measles cases rise to 4,080, CDC says - Reuters
US measles cases rise to 4,080, CDC says Reuters
October 9, 2026 at 05:45 PM